Ulrik Svane Sørensen
Fundador en Acesion Pharma ApS .
Perfil
Ulrik Svane Sørensen is the founder and the Chief Operating Officer of Acesion Pharma ApS, a company he founded in 2011.
He has held this position since 2016.
Dr. Sørensen also has an education background, having studied at Copenhagen Business School where he obtained an undergraduate degree and a doctorate.
Cargos activos de Ulrik Svane Sørensen
| Empresas | Cargo | Inicio |
|---|---|---|
Acesion Pharma ApS
 Acesion Pharma ApS Pharmaceuticals: MajorHealth Technology Acesion Pharma ApS develops drugs for the treatment of atrial fibrillation (AF), the most common type of cardiac arrhythmia. The firm's technology blocks ion channel with a selective drug molecule constitutes a target for developing treatment of AF. The company was founded by Ulrik Svane S?rensen and Morten Grunnet in 2011 and is headquartered in Copenhagen, Denmark. | Fundador | 01/01/2011 |
Formación de Ulrik Svane Sørensen.
| Copenhagen Business School | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Acesion Pharma ApS
Acesion Pharma ApS Pharmaceuticals: MajorHealth Technology Acesion Pharma ApS develops drugs for the treatment of atrial fibrillation (AF), the most common type of cardiac arrhythmia. The firm's technology blocks ion channel with a selective drug molecule constitutes a target for developing treatment of AF. The company was founded by Ulrik Svane S?rensen and Morten Grunnet in 2011 and is headquartered in Copenhagen, Denmark. | Health Technology |
- Bolsa de valores
- Insiders
- Ulrik Svane Sørensen
